SCHEMBL17852148

SCHEMBL17852148

CCOC(=O)c1ccc(Br)cc1-c1cc2ccccc2c2ccccc12

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.49
SMN1; SMN2 Q16637 2/20 0.49
CDC25B P30305 4/20 0.48
CDC25A P30304 1/20 0.48
CDC25C P30307 1/20 0.48
KDM4E B2RXH2 3/20 0.47
GLA P06280 1/20 0.47
GAA P10253 1/20 0.47
TSHR P16473 1/20 0.46
GABRA1 P14867 1/20 0.45
GABRB1 P18505 1/20 0.45
GABRA3 P34903 1/20 0.45
GABRB2 P47870 1/20 0.45
KMT2A Q03164 2/20 0.44
MEN1 O00255 1/20 0.44
RXFP1 Q9HBX9 1/20 0.44
LMNA P02545 2/20 0.44
ALOX5 P09917 2/20 0.43
PTGES O14684 1/20 0.43
CA12 O43570 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17836985 0.87 CDC25B (0.54) ALDH1A1SMN1; SMN2CDC25BCDC25ACDC25C
SCHEMBL8158480 0.85 CA12 (0.57) ALDH1A1SMN1; SMN2TSHRGABRA1GABRB1
SCHEMBL17841037 0.80 KDM4E (0.56) ALDH1A1SMN1; SMN2CDC25BCDC25ACDC25C
SCHEMBL19110412 0.80 GABRP (0.46) ALDH1A1SMN1; SMN2KDM4EGLAGAA
SCHEMBL17852149 0.80 SLC6A2 (0.52) ALDH1A1SMN1; SMN2CDC25BKDM4EGLA
SCHEMBL15505863 0.80 CDC25B (0.48) ALDH1A1CDC25BCDC25ACDC25CKDM4E
SCHEMBL14141531 0.79 TSHR (0.59) ALDH1A1CDC25BCDC25ACDC25CKDM4E
SCHEMBL17852127 0.78 ALOX5 (0.51) ALDH1A1SMN1; SMN2CDC25BCDC25ACDC25C
SCHEMBL6297205 0.77 CDC25B (0.57) ALDH1A1SMN1; SMN2CDC25BCDC25ACDC25C
SCHEMBL12594725 0.76 CDC25B (0.47) ALDH1A1CDC25BCDC25ACDC25CKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160181542-A1 ANTHRACENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT ELEMENT USING SAME IDEMITSU KOSAN CO., LTD. (JP) 2016-06-23 US disclosed
US-20160181542-A1 ANTHRACENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT ELEMENT USING SAME IDEMITSU KOSAN CO., LTD. (JP) 2016-06-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160181542-A1 ANTHRACENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT ELEMENT USING SAME L1CAM, H1-10, H1-0 ALDH1A1 605/4885SMN1; SMN2 2733/4885CDC25B 3875/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.